-
New changes in medicine: pharma to the left, commercialization platform to the right
The third party commercialization platform.
2023-04-27 16:07 -
Faith Medicine AAV gene therapy completed the phase III clinical enrollment of hemophilia B.
Faith Medical Hemophilia B gene therapy successfully completed Phase III registration clinical trial subjects.
2023-04-27 15:59 -
Hengrui entered the top 20 for the first time. How big is the gap between Chinese and American pharm...
Heavy sales but light research and development, when can Chinese pharmaceutical companies catch up with the United States?
2023-04-27 15:57 -
RATIONALE 306 to RATIONALE 305 Operation path for Beigene
RATIONALE306 to RATIONALE305.
2023-04-27 15:50 -
From Nobel Prize to Miracle Drug, Why did rat nerve growth Factor fall from its pedestal?
Annual sales are 3.3 billion.
2023-04-18 10:54 -
Multiple product indications withdrawn, FDA accelerated Approval How to reform?
Is AA Path Reform Inevitable?
2023-04-18 10:52 -
Revenue 37.7 billion, net profit 2.6 billion, East China medicine 'double increase' era
A typical case of successful transformation.
2023-04-18 10:50 -
Cure diabetes and obesity with printed materials? Novo Nordisk Introduces Cell Therapy for $2.6 bill...
What's new about bioprinting tissue therapy?
2023-04-18 10:48 -
-
Discovery of a Potential new target for ALS Drugs to curb protein misfolding!
When the SCFD1 gene is turned off, the cell's ability to fold proteins is impaired.
2023-04-18 10:45
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- Covestro and Wanhua Reshape Gl... Aug 20, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
